1. Home
  2. BKU vs EVO Comparison

BKU vs EVO Comparison

Compare BKU & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BankUnited Inc.

BKU

BankUnited Inc.

HOLD

Current Price

$43.47

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.42

Market Cap

821.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKU
EVO
Founded
2009
1993
Country
United States
Germany
Employees
N/A
4766
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
821.2M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
BKU
EVO
Price
$43.47
$2.42
Analyst Decision
Hold
Strong Buy
Analyst Count
11
1
Target Price
$52.18
$7.00
AVG Volume (30 Days)
734.5K
108.5K
Earning Date
04-27-2026
05-05-2026
Dividend Yield
3.05%
N/A
EPS Growth
14.61
N/A
EPS
3.53
N/A
Revenue
$21,732,000.00
N/A
Revenue This Year
$16.55
N/A
Revenue Next Year
$4.77
$7.13
P/E Ratio
$12.29
N/A
Revenue Growth
7.45
N/A
52 Week Low
$28.21
$2.31
52 Week High
$52.11
$4.80

Technical Indicators

Market Signals
Indicator
BKU
EVO
Relative Strength Index (RSI) 35.87 28.78
Support Level $37.36 $2.31
Resistance Level $46.92 $3.78
Average True Range (ATR) 1.26 0.09
MACD -0.24 -0.04
Stochastic Oscillator 22.42 9.98

Price Performance

Historical Comparison
BKU
EVO

About BKU BankUnited Inc.

BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: